risperidone has been researched along with pf-2545920 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chappie, TA; Helal, CJ; Hou, X | 1 |
| Avhad, VB; Bajpai, M; Bhateja, DK; Das, S; Gandhi, MN; Gudi, GS; Gullapalli, S; Gupta, PK; Harde, RL; Jadhav, SB; Joshi, AA; Khairatkar-Joshi, N; Mahat, MY; Marathe, MY; Shelke, DE; Thomas, A | 1 |
2 other study(ies) available for risperidone and pf-2545920
| Article | Year |
|---|---|
Current landscape of phosphodiesterase 10A (PDE10A) inhibition.
Topics: Animals; Cyclic AMP; Cyclic GMP; Humans; Hydrolysis; Mice; Models, Molecular; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats | 2012 |
Design, synthesis and pharmacological evaluation of novel polycyclic heteroarene ethers as PDE10A inhibitors: part II.
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Drug Design; Ethers; Haplorhini; Humans; Male; Mice; Molecular Structure; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2014 |